Amanote Research
Register
Sign In
Correction: Quality of Life in Long-Term Survivors of Advanced Melanoma Treated With Checkpoint Inhibitors
Journal for ImmunoTherapy of Cancer
- United Kingdom
doi 10.1136/jitc-2019-000260corr1
Full Text
Open PDF
Abstract
Available in
full text
Categories
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
Date
April 1, 2020
Authors
Unknown
Publisher
BMJ
Related search
Recurrent Pneumonitis in Patients With Melanoma Treated With Immune Checkpoint Inhibitors
Oncologist
Cancer Research
Medicine
Oncology
Quality of Life Among Long-Term Survivors of Head and Neck Cancer Treated by Intensity-Modulated Radiotherapy
JAMA Otolaryngology - Head and Neck Surgery
Medicine
Otorhinolaryngology
Surgery
Quality of Life, Long-Term Survivors and Long-Term Outcome From the ABC-02 Study
British Journal of Cancer
Cancer Research
Oncology
Rechallenge With Checkpoint Inhibitors in Metastatic Melanoma
JDDG - Journal of the German Society of Dermatology
Dermatology
Long-Term Outcome and Quality of Life in Aortic Type a Dissection Survivors
Thoracic and Cardiovascular Surgeon
Respiratory Medicine
Surgery
Cardiovascular Medicine
Pulmonary
Cardiology
Long-Term Quality of Life in Patients With Advanced Hodgkin Lymphoma: A Systematic Review
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Impact of Clinicopathological Characteristics on Survival in Patients Treated With Immune Checkpoint Inhibitors for Metastatic Melanoma
International Journal of Cancer
Cancer Research
Oncology
Palliative Radiotherapy in Advanced Cancer Patients Treated With Immune‑checkpoint Inhibitors: The PRACTICE Study
Biomedical Reports
Genetics
Pharmacology
Molecular Biology
Biochemistry
Neuroscience
Medicine
Toxicology
Pharmaceutics
Motivational Readiness for Physical Activity and Quality of Life in Long-Term Lung Cancer Survivors
Lung Cancer
Cancer Research
Oncology
Respiratory Medicine
Pulmonary